The Winner Is… Biometrik!

Writer by Ayu Three Wiji Latifah, Editor by Balqist Nadia Rahmah

PT. Biometrik Riset Indonesia won the tender for the amlodipine bioequivalence study held by the Ministry of Health of the Republic of Indonesia and succeeded in defeating several Bioequivalence Laboratory participants who participated in this tender. The website officially announced this victory on Monday, May 22, 2023.

The tender for the bioequivalence study held by the Ministry of Health of the Republic of Indonesia aims to test domestically produced amlodipine raw materials. The future goal is that the raw material for amlodipine does not need to be imported. The use of domestic products will also show the ability and independence of the nation's economy. Therefore, our nation’s dependency on imported products will be reduced.

This victory will allow Biometrik to cooperate with 15 pharmaceutical companies spread across Indonesia. Biometrik will carry out this tender with high capability and enthusiasm so that it can provide the best results for the progress of the pharmaceutical industry. We hope that this victory will increase the spirit of Biometrik to continue providing Independency, Integrity, and reliable bioequivalence study.